Genetic predispositions are increasingly being diagnosed, discussed or suspected to explain childhood cancers. We will consider describing how a predisposition syndrome leads to cancer, how to interpret variants and how to validate their pathological character, both clinically and in research. We will discuss the merits of surveillance programs, and address through case discussions how to approach the complexity of genetic information management at all levels.
Round Table: How to establish surveillance guidelines
N/A
Samuel ABBOU – FR
Isabelle AERTS – FR
Gaelle BOUGEARD - FR
Franck BOURDEAUT - FR
Guillaume CANAUD - FR
Olivier CARON - FR
Sarah CARVALLO - FR
David CASTEL - FR
Hélène CAVÉ - FR
Chrystelle COLAS - FR
Nadège CORRADINI - FR
Volodia DANGOULOFF-ROSS - FR
Olivier DELATTRE - FR
Youenn DROUET - FR
Léa GUERRINI-ROUSSEAU - FR
Julia HAUER - DE
Jurriaan HOLZENSPIES - NL
Marjolijn JONGMANS - NL
Khadidja LAHLOU-LAFORÊT - FR
Lise LARCHER – FR
Sylvain LATOUR - FR
Thierry LEBLANC - FR
Martine MULERIS - FR
Irene ROBERTS - UK
Piotr TOPILKO - FR
Jean-Pierre de VILLARTAY - FR
Sebastian WASZAK - CH
Joshua WATERFALL - FR
Jessica ZUCMAN-ROSSI - FR
Laurent ABEL – FR
This list of speakers may still change
Franck Bourdeaut, Institut Curie
Hélène Cavé, AP-HP
Chrystelle Colas, Institut Curie
Léa Guerrini-Rousseau, Gustave Roussy
Sylvain Latour, Institut Imagine
Annaelle Marey, Institut Curie
Franck Bourdeaut, Institut Curie
Hélène Cavé, AP-HP
Chrystelle Colas, Institut Curie
Léa Guerrini-Rousseau, Gustave Roussy
Sylvain Latour, Institut Imagine
From November 22 to 24 at Institut Curie (11 Rue Pierre et Marie Curie, 75005 PARIS - Bâtiment de Biologie du Développement - Amphithéâtre)
40 participants
Based on resume and motivation
